With the widespread legalization of marijuana nationwide, extra American staff are producing constructive drug assessments in screenings.
A brand new report by Cision discovered that, in 2022, 4.3% of American staff examined constructive for marijuana — up from 3.9% in 2021 and the very best stage in 25 years. These numbers rise much more in states the place leisure marijuana is authorized (5.7%).
Moreover, the variety of staff who examined constructive for the drug following an on-the-job accident rose to 7.3%, tripling since 2012.
“Intoxicating hashish merchandise, together with marijuana, can have a serious impression on security at work and have been confirmed to gradual response time, impression reminiscence, and impair abilities important to driving,” Katie Mueller, a senior program supervisor on the Nationwide Security Council specializing in hashish security, stated within the report. “State legalization of the drug creates new challenges for employers.”
Throughout all industries, marijuana positivity was highest within the retail, lodging, and meals service sectors at 8.1%.
The report additionally discovered that constructive drug assessments throughout all substances was 4.6% in 2022, the very best since 2001. The info notes marijuana as the primary driver within the enhance, with amphetamines as a detailed second. From 2012 to 2021, the variety of Individuals who examined constructive for amphetamines rose by 7.4%, in line with Quest Diagnostics. The report additionally discovered that 49% of people examined confirmed indicators of prescription drug misuse of managed drugs.
“The rise in amphetamines positivity can also be notable, given the addictive potential and well being dangers related to this class of medication,” Keith Ward, common supervisor and vice chairman for employer options at Quest Diagnostics stated within the Cision report.
Associated: The Billion-Greenback Enterprise of CBD (Infographic)
